This is a free program for healthcare professionals worldwide, across all disciplines who want to improve their ability to care for people with EDS, HSD and associated symptoms and conditions.
Please complete the application form below to apply for a place on the EDS ECHO Pediatrics, North America Program.
EDS ECHO Pediatrics, North America – Program Details:
Module 2 is designed for those with a background understanding of EDS and HSD who wish to develop their understanding and skills in managing complex, co-morbid concerns.
|Program: EDS ECHO Pediatrics, North America (Module 2)||Clinical Lead: Dr. Sarah Scwartz and Ms Connir O’Connor|
Date & Time: Tuesdays at 12:00pm – 1:00pm Eastern Time (US & Canada)
|Session 1 – Psychological and Social Concerns in Hypermobility and EDS||October 5, 2021|
|Session 2 – Cardiovascular Concerns and Management in Hypermobility and EDS||October 12, 2021|
|Session 3 – GI Issues and Management in Hypermobility and EDS||October 19, 2021|
|Session 4 – Neurological Assessment and Management in Hypermobility and EDS||October 26, 2021|
|Session 5 – Challenges in Patient Care and Complex Cases||November 2, 2021|
The program content is currently only presented in English.
This is a virtual program, you will be sent a link to join the sessions which are run via the zoom platform. Once signed up, we ask that you attend a minimum of 3 out of the 5 sessions. You can catch up with the sessions you miss by watching our password protected recordings online. For all queries regarding EDS ECHO, please email our EDS ECHO Program Coordinator.
Each EDS ECHO session is worth 1.0 CME/CEU/CE credit per 60 minutes of live session learning.
For more information, visit our dedicated EDS ECHO Pediatrics web page.
Please complete and submit the following information to apply for a place on the program:
In support of improving patient care, this activity has been planned and implemented by The Ehlers-Danlos Society and Project ECHO®. Project ECHO® is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA Designation Statement
Project ECHO® designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™ per 60 minutes. Clinicians should claim only the credit commensurate with the extent of their participation in the activity.
Project ECHO®, in compliance with the ACCME Standards of Commercial Support, requires anyone who is in a position to control the content of an activity discloses all relevant financial relationships they have had within the last 12 months with a commercial interest related to the content of the activity.
The Planners and Presenters of this activity disclose that they have no financial relationships with any commercial interest. Alan Hakim, MD; Sarah Schwartz, MD; Connie O’Connor, MD; Paul Gardener; Stacey Simmonds; Owen Moore; Ramandeep Sran.